B-Type Natriuretic Peptide as a Significant Brain Biomarker for Stroke Triaging Using a Bedside Point-of-Care Monitoring Biosensor
Stroke is a widespread condition that causes 7 million deaths globally. Survivors suffer from a range of disabilities that affect their everyday life. It is a complex condition and there is a need to monitor the different signals that are associated with it. Stroke patients need to be rapidly diagno...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Biosensors |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6374/10/9/107 |
id |
doaj-3a610d6c319a4c66af3ddb7e6f85c356 |
---|---|
record_format |
Article |
spelling |
doaj-3a610d6c319a4c66af3ddb7e6f85c3562020-11-25T02:58:56ZengMDPI AGBiosensors2079-63742020-08-011010710710.3390/bios10090107B-Type Natriuretic Peptide as a Significant Brain Biomarker for Stroke Triaging Using a Bedside Point-of-Care Monitoring BiosensorDorin Harpaz0Raymond C. S. Seet1Robert S. Marks2Alfred I. Y. Tok3School of Material Science & Engineering, Nanyang Technology University, 50 Nanyang Avenue, Singapore 639798, SingaporeDivision of Neurology, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, NUHS Tower Block, 1E Kent Ridge Road, Singapore 119228, SingaporeDepartment of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva 84105, IsraelSchool of Material Science & Engineering, Nanyang Technology University, 50 Nanyang Avenue, Singapore 639798, SingaporeStroke is a widespread condition that causes 7 million deaths globally. Survivors suffer from a range of disabilities that affect their everyday life. It is a complex condition and there is a need to monitor the different signals that are associated with it. Stroke patients need to be rapidly diagnosed in the emergency department in order to allow the admission of the time-limited treatment of tissue plasminogen activator (tPA). Stroke diagnostics show the use of sophisticated technologies; however, they still contain limitations. The hidden information and technological advancements behind the utilization of biomarkers for stroke triaging are significant. Stroke biomarkers can revolutionize the way stroke patients are diagnosed, monitored, and how they recover. Different biomarkers indicate different cascades and exhibit unique expression patterns which are connected to certain pathologies in the human body. Over the past decades, B-type natriuretic peptide (BNP) and its derivative N-terminal fragment (NT-proBNP) have been increasingly investigated and highlighted as significant cardiovascular biomarkers. This work reviews the recent studies that have reported on the usefulness of BNP and NT-proBNP for stroke triaging. Their classification association is also presented, with increased mortality in stroke, correlation with cardioembolic stroke, and an indication of a second stroke recurrence. Moreover, recent scientific efforts conducted for the technological advancement of a bedside point-of-care (POC) device for BNP and NT-proBNP measurements are discussed. The conclusions presented in this review may hopefully assist in the major efforts that are currently being conducted in order to improve the care of stroke patients.https://www.mdpi.com/2079-6374/10/9/107strokediagnosticsbiomarkerb-type natriuretic peptidepoint-of-carebiosensor |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Dorin Harpaz Raymond C. S. Seet Robert S. Marks Alfred I. Y. Tok |
spellingShingle |
Dorin Harpaz Raymond C. S. Seet Robert S. Marks Alfred I. Y. Tok B-Type Natriuretic Peptide as a Significant Brain Biomarker for Stroke Triaging Using a Bedside Point-of-Care Monitoring Biosensor Biosensors stroke diagnostics biomarker b-type natriuretic peptide point-of-care biosensor |
author_facet |
Dorin Harpaz Raymond C. S. Seet Robert S. Marks Alfred I. Y. Tok |
author_sort |
Dorin Harpaz |
title |
B-Type Natriuretic Peptide as a Significant Brain Biomarker for Stroke Triaging Using a Bedside Point-of-Care Monitoring Biosensor |
title_short |
B-Type Natriuretic Peptide as a Significant Brain Biomarker for Stroke Triaging Using a Bedside Point-of-Care Monitoring Biosensor |
title_full |
B-Type Natriuretic Peptide as a Significant Brain Biomarker for Stroke Triaging Using a Bedside Point-of-Care Monitoring Biosensor |
title_fullStr |
B-Type Natriuretic Peptide as a Significant Brain Biomarker for Stroke Triaging Using a Bedside Point-of-Care Monitoring Biosensor |
title_full_unstemmed |
B-Type Natriuretic Peptide as a Significant Brain Biomarker for Stroke Triaging Using a Bedside Point-of-Care Monitoring Biosensor |
title_sort |
b-type natriuretic peptide as a significant brain biomarker for stroke triaging using a bedside point-of-care monitoring biosensor |
publisher |
MDPI AG |
series |
Biosensors |
issn |
2079-6374 |
publishDate |
2020-08-01 |
description |
Stroke is a widespread condition that causes 7 million deaths globally. Survivors suffer from a range of disabilities that affect their everyday life. It is a complex condition and there is a need to monitor the different signals that are associated with it. Stroke patients need to be rapidly diagnosed in the emergency department in order to allow the admission of the time-limited treatment of tissue plasminogen activator (tPA). Stroke diagnostics show the use of sophisticated technologies; however, they still contain limitations. The hidden information and technological advancements behind the utilization of biomarkers for stroke triaging are significant. Stroke biomarkers can revolutionize the way stroke patients are diagnosed, monitored, and how they recover. Different biomarkers indicate different cascades and exhibit unique expression patterns which are connected to certain pathologies in the human body. Over the past decades, B-type natriuretic peptide (BNP) and its derivative N-terminal fragment (NT-proBNP) have been increasingly investigated and highlighted as significant cardiovascular biomarkers. This work reviews the recent studies that have reported on the usefulness of BNP and NT-proBNP for stroke triaging. Their classification association is also presented, with increased mortality in stroke, correlation with cardioembolic stroke, and an indication of a second stroke recurrence. Moreover, recent scientific efforts conducted for the technological advancement of a bedside point-of-care (POC) device for BNP and NT-proBNP measurements are discussed. The conclusions presented in this review may hopefully assist in the major efforts that are currently being conducted in order to improve the care of stroke patients. |
topic |
stroke diagnostics biomarker b-type natriuretic peptide point-of-care biosensor |
url |
https://www.mdpi.com/2079-6374/10/9/107 |
work_keys_str_mv |
AT dorinharpaz btypenatriureticpeptideasasignificantbrainbiomarkerforstroketriagingusingabedsidepointofcaremonitoringbiosensor AT raymondcsseet btypenatriureticpeptideasasignificantbrainbiomarkerforstroketriagingusingabedsidepointofcaremonitoringbiosensor AT robertsmarks btypenatriureticpeptideasasignificantbrainbiomarkerforstroketriagingusingabedsidepointofcaremonitoringbiosensor AT alfrediytok btypenatriureticpeptideasasignificantbrainbiomarkerforstroketriagingusingabedsidepointofcaremonitoringbiosensor |
_version_ |
1724704401888641024 |